Stromal gene expression predicts clinical outcome in breast cancer-Reference-Cited by-同舟云学术

Stromal gene expression predicts clinical outcome in breast cancer

Published:2008-04-27 Issue:5 Volume:14 Page:518-527
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Finak Greg,Bertos Nicholas,Pepin Francois,Sadekova Svetlana,Souleimanova Margarita,Zhao Hong,Chen Haiying,Omeroglu Gulbeyaz,Meterissian Sarkis,Omeroglu Atilla,Hallett Michael,Park Morag

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm1764.pdf

Reference49 articles.

1. Kamangar, F., Dores, G.M. & Anderson, W.F. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J. Clin. Oncol. 24, 2137–2150 (2006).

2. van 't Veer, L.J. et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530–536 (2002).

3. van de Vijver, M.J. et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347, 1999–2009 (2002).

4. Perou, C.M. et al. Molecular portraits of human breast tumours. Nature 406, 747–752 (2000).

5. Wang, Y. et al. Gene-expression profiles to predict distant metastasis of lymph-node–negative primary breast cancer. Lancet 365, 671–679 (2005).

Cited by 1391 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-genetic heterogeneity and immune subtyping in breast cancer: Implications for immunotherapy and targeted therapeutics;Translational Oncology;2024-09

2. Targeting amino acid-metabolizing enzymes for cancer immunotherapy;Frontiers in Immunology;2024-08-14

3. Targeting fatty acid oxidation enhances response to HER2-targeted therapy;Nature Communications;2024-08-03

4. Populations of triple negative and hormone receptor positive HER2 negative breast tumors share immune gene profiles;2024-08-02

5. Differential Abundance of DNA Damage Sensors and Innate Immune Signaling Proteins in Inositol Polyphosphate 4-Phosphatase Type II–Negative Triple-Negative Breast Cancer Classified by Immunotype;The American Journal of Pathology;2024-08